Publications by authors named "Roberto Camerini"

Claim this Profile
C
Corrigendum to "Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial" [Eur J Cancer 199 (2024) 113531].
Anna Maria Di Giacomo, Vanna Chiarion-Sileni, Michele Del Vecchio, Pier Francesco Ferrucci, Michele Guida, Roberto Camerini

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial.
Anna Maria Di Giacomo, Vanna Chiarion-Sileni, Michele Del Vecchio, Pier Francesco Ferrucci, Michele Guida, Roberto Camerini

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
Stefania Capone, Francesco M Fusco, Stefano Milleri, Silvio Borrè, Sergio Carbonara, Roberto Camerini

Cell Rep Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results.
Chiara Agrati, Concetta Castilletti, Simone Battella, Eleonora Cimini, Giulia Matusali, Roberto Camerini

NPJ Vaccines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults.
Simone Lanini, Stefania Capone, Andrea Antinori, Stefano Milleri, Emanuele Nicastri, Roberto Camerini

Sci Transl Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19.
Chiara Agrati, Stefania Capone, Concetta Castilletti, Eleonora Cimini, Giulia Matusali, Roberto Camerini

NPJ Vaccines· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases.
Anna Maria Di Giacomo, Vanna Chiarion-Sileni, Michele Del Vecchio, Pier Francesco Ferrucci, Michele Guida, Roberto Camerini

Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.
Riccardo Danielli, Filomena Cisternino, Diana Giannarelli, Luana Calabrò, Roberto Camerini

Expert Opin Biol Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical review of thymosin α 1 in infectious diseases.
Roberto Camerini, Enrico Garaci

Expert Opin Biol Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
Enrico Garaci, Francesca Pica, Claudia Matteucci, Roberta Gaziano, Cartesio D'Agostini, Roberto Camerini

Expert Opin Biol Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature.
Maria Giovanna Scioli, Maria Antonietta Stasi, Daniela Passeri, Elena Doldo, Gaetana Costanza, Roberto Camerini

Clin Transl Gastroenterol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.
Michele Maio, Hugues Jean Marie Nicolay, Paolo Antonio Ascierto, Filippo Belardelli, Roberto Camerini

Cancer Immunol Immunother· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymosin α1 continues to show promise as an enhancer for vaccine response.
Cynthia Tuthill, Israel Rios, Alfonso De Rosa, Roberto Camerini

Ann N Y Acad Sci· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer.
Michele Maio, Hugues J M Nicolay, Paolo A Ascierto, Filippo Belardelli, Roberto Camerini

Cancer Immunol Immunother· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current adjuvants and new perspectives in vaccine formulation.
Emanuele Montomoli, Simona Piccirella, Baharak Khadang, Elisa Mennitto, Roberto Camerini

Expert Rev Vaccines· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.
Michele Maio, Hugues J M Nicolay, Paolo A Ascierto, Filippo Belardelli, Roberto Camerini

Cancer Immunol Immunother· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.
Michele Maio, Hugues J M Nicolay, Paolo A Ascierto, Filippo Belardelli, Roberto Camerini

Cancer Immunol Immunother· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.
Michele Maio, Hugues J M Nicolay, Paolo A Ascierto, Filippo Belardelli, Roberto Camerini

Cancer Immunol Immunother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.
Michele Maio, Andrzej Mackiewicz, Alessandro Testori, Uwe Trefzer, Virginia Ferraresi, Roberto Camerini

J Clin Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.
Michele Maio, Hugues Jm Nicolay, Paolo Ascierto, Filippo Belardelli, Roberto Camerini

J Transl Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing.
Giorgio Guarnera, Alfonso DE Rosa, Roberto Camerini

Ann N Y Acad Sci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C.
Roberto Camerini, Alessia Ciancio, Alfonso DE Rosa, Mario Rizzetto

Ann N Y Acad Sci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.
Licia Rivoltini, Chiara Castelli, Matteo Carrabba, Vincenzo Mazzaferro, Lorenzo Pilla, Roberto Camerini

J Immunol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.
Vincenzo Mazzaferro, Jorgelina Coppa, Matteo G Carrabba, Licia Rivoltini, Marcello Schiavo, Tiziana Camerini, Roberto Camerini

Clin Cancer Res· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.
Filiberto Belli, Alessandro Testori, Licia Rivoltini, Michele Maio, Giovanna Andreola, Roberto Camerini

J Clin Oncol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis